Establishment and validation of nomogram for predicting immuno checkpoint inhibitor related pneumonia

OBJECTIVE: Cancer is one of the main causes of death worldwide. Although immunotherapy brings hope for cancer treatment, it is also accompanied by immune checkpoint inhibitor-related adverse events (irAEs). Immune checkpoint inhibitor pneumonia (CIP) is a potentially fatal adverse event, but there i...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xiaoqi, Lv, Fei, Wang, Ying, Du, Zhenguang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9436165/
https://www.ncbi.nlm.nih.gov/pubmed/36050683
http://dx.doi.org/10.1186/s12890-022-02127-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9436165/
https://www.ncbi.nlm.nih.gov/pubmed/36050683
http://dx.doi.org/10.1186/s12890-022-02127-3

Ejemplares similares